COSA 2014* , ,
Presentations this author is a contributor to:
The new selective GLP-2 receptor agonist, Elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat. (#224)
3:00 PM
Bronwen Mayo
Poster discussion 1
Apoptosis, proliferation and inflammation are improved after treatment with the new selective GLP-2 receptor agonist, Elsiglutide, in a rat model of irinotecan-induced mucositis. (#225)
3:00 PM
Bronwen Mayo
Poster discussion 1